BRK-B vs HTGC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
HTGC presents a stark contrast between deep fundamental value and deteriorating financial health markers. While the Piotroski F-Score of 2/9 indicates weak operational health and the technical trend is bearish, the stock trades significantly below its Graham Number ($22.61) and Intrinsic Value ($54.58). Strong growth in revenue and earnings is offset by a concerning dividend payout ratio of 101.62%, suggesting the current yield is unsustainable. The valuation is highly attractive, but the deterministic health scores necessitate a cautious approach.
Compare Another Pair
Related Comparisons
BRK-B vs HTGC: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Hercules Capital, Inc. (HTGC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.